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Background
Symptoms of anxiety and depression are prevalent in older
adults.
Aims
To compare clinician-guided and self-guided versions of a
transdiagnostic internet-delivered cognitive–behavioural
therapy (iCBT) intervention for adults aged 60 years and above.
Method
Adults (n=433) with symptoms of anxiety and depression were
randomly allocated to: (1) clinician-guided treatment (n=153);
(2) initial clinician interview followed by self-guided treatment
(n=140); or (3) self-guided treatment without interview (n=140).
Results
Large reductions (d ≥1.00) in symptoms of depression and
anxiety were observed across groups, and sustained at
follow-up. No differences were observed in clinical outcomes or
satisfaction ratings. Age did not affect outcomes.
Conclusions
Carefully developed iCBT interventions may significantly reduce
symptoms of anxiety and depression in older adults when
delivered in either clinician-guided or self-guided formats.
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Clinical and subclinical levels of depression and anxiety are
common in older adults,1–3 and are associated with reduced
quality of life, increased disability and increased risk of suicide.4
Treatments such as cognitive–behavioural therapy (CBT) are
known to be effective,5,6 but only a small proportion of older
people with depression and anxiety seek or receive evidence-based
treatment.7,8 Barriers to care include stigma, costs of treatment,
mobility limitations and the limited number of trained therapists,
which can all be reduced using internet-delivered CBT (iCBT).9
iCBT can be supported by a clinician, provided as a self-guided
treatment with an initial interview followed by monitoring of
outcomes, or provided in a fully automated manner without
contact or monitoring. In studies conducted to date, clinician-
guided iCBT has been associated with superior outcomes relative
to self-guided and fully automated iCBT.10 However, recently
developed self-guided iCBT, which include automated prompts
and other strategies designed to increase completion rates, has
shown levels of clinical improvement equivalent to clinician-
guided treatment.11–15 Whereas several studies have demonstrated
the efficacy of iCBT in treating anxiety and depression in older
adults,16–22 there have been no trials directly comparing guided
and self-guided iCBT with this population. The comparison is
warranted because we do not know whether older adults require
additional support to benefit from self-guided iCBT, which can in
turn affect the cost of making this treatment widely available.
The present study compared the efficacy and acceptability of
an iCBT intervention delivered with varying levels of clinician
guidance. The Wellbeing Plus Course is a transdiagnostic inter-
vention designed for adults aged 60 years and above with anxiety
or depression. Participants were randomised to clinician-guided or
self-guided iCBT groups, with the latter receiving either an
orientation interview or no interview. It was hypothesised that
all groups would report significant improvements on measures of
anxiety and depression but that the clinician-guided group would
obtain superior outcomes, and that the outcomes of the self-
guided group which received an orientation interview would be
superior to the other self-guided group. It was also hypothesised




The study was promoted in newspapers and online, and
participants were recruited via a specialist research unit (www.
ecentreclinic.org) that provides information about common men-
tal and chronic health conditions and offers free psychological
treatment via participation in clinical trials. The CONSORT
flowchart for the trial is displayed in Fig. 1. A total of 563
individuals applied to participate in the study and 459 met the
criteria for inclusion. The inclusion criteria were: (a) resident of
Australia, (b) at least 60 years of age and (c) a principal complaint
of symptoms of anxiety or depression. The exclusion criteria were:
(a) current participation in CBT and (b) very severe symptoms of
depression (defined as a total score ≥24 or responding >2 to
Question 9 on the 9-item Patient Health Questionnaire (PHQ-9).23
Questions pertaining to the inclusion and exclusion criteria were
assessed via an online application form.
Applicants meeting inclusion criteria were randomly allocated
at the point of application to one of three treatment groups,
using a permuted block randomisation sequence generated by
B.F.D.: (a) interview plus clinician-guided group (iCG; n=158);
(b) interview plus self-guided group (iSG; n=147); or (c) self-guided
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group (SG; n=154). The randomisation sequence was created by
B.F.D. using an online randomiser (www.random.org) and partici-
pant randomisation occurred at the point of application, via the
eCentreClinic software system, before participants had any contact
with the researchers or the researchers had the opportunity to
review the details of participants’ applications. Thus, the
researchers were masked to group allocation until the partici-
pant was deemed to have made a successful or unsuccessful
application. The study was approved by the Human Research
Ethics Committee (HREC) of Macquarie University, Sydney,
Australia, and the trial was registered on the Australian and
New Zealand Clinical Trials Registry (ANCZTR) as
ACTRN12613000958785.
Design and measures
The study employed a three-arm CONSORT-revised compliant
randomised controlled trial (RCT) comparing an internet-
delivered treatment for older adults provided with three levels of
support. The researchers sought to recruit at least 450 participants,
which, with alpha set at 0.05 and a power of 0.80, would enable
the detection of small effect size differences (i.e. Cohen’s d>0.35)
between groups. All outcome measures were collected via online
questionnaires. The primary measures of anxiety and depression
were administered weekly to monitor participants’ progress and
safety throughout treatment. The secondary and tertiary measures
were administered at pre-treatment, post-treatment and 3-month
follow-up, and the acceptability and satisfaction questions were
administered post-treatment.
Primary measures
Two primary measures were used to assess the presence and
severity of depression and anxiety: the PHQ-9, a 9-item measure
of the presence and severity of symptoms of depression, based on
the DSM-IV diagnostic criteria for major depressive disorder;23
and the 7-item Generalised Anxiety Disorder scale (GAD-7), a 7-
item measure of the presence and severity of symptoms of general
anxiety, which is based on the DSM-IV diagnostic criteria for
GAD.24
Secondary measures
Two secondary measures were used: the Geriatric Depression
Scale (GDS), a 15-item short-form screening measure for the
assessment and detection of depression among older adults. The
GDS employs a simple ‘Yes’ or ‘No’ response, and places less
emphasis on the somatic symptoms of depression, which are often
confounded in older adults by other physical conditions.25 The 10-
item Kessler Psychological Distress Scale (K-10) was used to
measure general psychological distress, with total scores ≥22
associated with a diagnosis of anxiety and depressive disorders.26
Excluded (n = 104)
Less than 60 years of age (n = 14)
Current participation in CBT (n = 6)
Unable to contact for interview (n = 9)
Withdrew prior to interview (n = 8)
Withdrew during interview (n = 8)
Incomplete application (n = 36)
Suicidal on initial exclusion question (n = 6)
Severe symptoms of depression on PHQ-9 (n = 13)
Primary complaint other than anxiety or depression (n = 4)
Successful applicants (n = 459)
563 individuals applied to participate in the Wellbeing Plus Course (25/03/2014 to 05/09/2014) 
3-month follow-up
Completed questionnaires (n = 147; 96%)
Formally withdrew from course (n = 0; 0%)
No response (n = 6; 4%)
3-month follow-up
Completed questionnaires (n = 126; 90%)
Formally withdrew from course (n = 1; 1%)
No response (n = 13; 9%)
3-month follow-up
Completed questionnaires (n = 131; 94%)
Formally withdrew from course (n = 1; 1%)
No response (n = 8; 6%)
Clinician-guided with interview (n = 158)
Did not complete pre-treatment 
questionnaires (n = 1)
Did not start lesson 1 (n = 4)
Self-guided with interview (n = 147)
Did not complete pre-treatment
questionnaires (n = 3) 
Did not start lesson 1 (n = 4)
Self-guided without interview (n = 154)
Did not complete pre-treatment questionnaires (n=8)
Did not start lesson 1 (n = 5)
Ineligible; enrolled on other’s behalf (n = 1)
Eligible for analysis (n = 153)
Completed lesson 1 (n = 153; 100%)
Completed lesson 2 (n = 152; 99%)
Completed lesson 3 (n = 150; 98%)
Completed lesson 4 (n = 146; 95%)
Completed lesson 5 (n = 140; 92%)
Eligible for analysis (n = 140)
Completed lesson 1 (n = 140; 100%)
Completed lesson 2 (n = 137; 98%)
Completed lesson 3 (n = 129; 92%)
Completed lesson 4 (n = 124; 89%)
Completed lesson 5 (n = 111; 79%)
Eligible for analysis (n = 140)
Completed lesson 1 (n = 140; 100%)
Completed lesson 2 (n = 133; 95%)
Completed lesson 3 (n = 128; 91%)
Completed lesson 4 (n = 121; 86%)
Completed lesson 5 (n = 111; 79%)
Post-treatment
Completed questionnaires (n = 150; 98%)
Formally withdrew from course (n = 1; 1%)
No response (n = 2; 1%)
Post-treatment
Completed questionnaires (n = 136; 97%)
Formally withdrew from course (n = 1; 1%)
No response (n = 3; 2%)
Post-treatment
Completed questionnaires (n = 133; 95%)
Formally withdrew from course (n = 4; 3%)
No response (n = 3; 2%)
Fig. 1 Participant flow from application to 3-month follow-up. CBT, cognitive–behavioural therapy; PHQ-9, 9-item Patient Health Questionnaire.
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Tertiary measures
Two tertiary measures were used: the Sheehan Disability Scale
(SDS), a 3-item measure of disability and functional impairment
in work, study, social life and family life and household
responsibilities,27 and the Satisfaction with Life Scale (SWLS), a
5-item measure of judgements of subjective well-being.28
Acceptability and satisfaction
Treatment satisfaction and acceptability were assessed at post-
treatment using two questions taken from other studies: (1)
‘Would you feel confident in recommending this course?’ and
(2) ‘Was it worth your time doing the course?’ Participants
responded with a ‘Yes’ or ‘No’ response.16,17,20
















Male 53 35 50 36 52 37 155 36 Wald’s χ2=0.20, P=0.905
Female 100 65 90 64 88 63 278 64
Age, years
Mean (s.d) 65 (3.8) 66 (4.6) 67 (5.6) 66 (4.7) F2,430=4.73, P=0.009
Range 60–78 60–80 60–93 60–93
Age frequency
60–64 years 78 51 69 49 63 45 210 49 Wald’s χ2=1.10, P=0.578
65–74 years 74 48 64 46 63 45 201 46 Wald’s χ2=0.37, P=0.829
75 years and above 1 1 7 5 14 10 22 5 Wald’s χ2=8.66, P=0.013
Marital status
Single/never married 8 5 8 6 3 2 19 4 Wald’s χ2=2.35, P=0.309
Married/de facto 96 63 98 70 99 71 293 68 Wald’s χ2=2.63, P=0.269
Separated/divorced/widowed/other 49 32 34 24 38 27 121 28 Wald’s χ2=2.23, P=0.328
Education
High school or less 32 21 27 19 26 19 85 20 Wald’s χ2=0.27, P=0.874
Certificate/diploma/other 43 28 37 27 47 33 127 29 Wald’s χ2=1.89, P=0.389
University 78 51 76 54 67 48 221 51 Wald’s χ2=1.16, P=0.561
Vocational statusa
Full-time/part-time employment 84 55 76 54 65 46 225 52 Wald’s χ23.57, P=0.168
Full-time/part-time student 1 1 4 3 2 1 7 2 Wald’s χ2=2.00, P=0.367
Unemployed/seeking employment 9 6 8 6 9 6 26 6 Wald’s χ2=0.07, P=0.966
Registered disability 4 3 5 4 4 3 13 3 Wald’s χ2=0.24, P=0.885
Retired 83 54 86 61 87 62 256 59 Wald’s χ2=2.34, P=0.311
Age at symptom onset, years: mean (s.d.) 33 (19) 33 (18) 35 (20) 33 (19) F2,423=0.50, P=0.609
Treatment in previous 12 months
Yes 53 35 45 32 51 36 149 34 Wald’s χ2=0.57, P=0.750
No 100 65 95 68 89 63 284 66
Health professionals seen for treatment
General practitioner 87 57 81 58 82 59 250 58 Wald’s χ2=0.09, P=0.957
Psychiatrist 9 6 7 5 7 5 108 25 Wald’s χ2=0.21, P=0.901
Psychologist/counsellor 39 26 36 26 33 24 23 5 Wald’s χ2=0.15, P=0.926
Other 14 9 10 7 10 7 34 8 Wald’s χ2=0.54, P=0.760
Taking prescription medication
No 101 66 89 65 98 70 288 67 Wald’s χ2=1.32, P=0.516
Anxiety 12 8 16 11 12 9 40 9 Wald’s χ2=1.21, P=0.544
Depression 19 12 19 14 15 11 53 12 Wald’s χ2=0.53, P=0.764
Both anxiety and depression 21 14 16 11 15 11 52 12 Wald’s χ2=0.69, P=0.708
Distribution of symptoms at assessment
Anxiety symptoms (GAD-7)
Minimal anxiety 18 12 8 6 10 7 36 8 Wald’s χ2=3.77, P=0.152
Mild anxiety 57 37 51 36 53 38 161 37 Wald’s χ2=0.62, P=0.970
Moderate anxiety 50 33 54 39 51 36 155 36 Wald’s χ2=1.14, P=0.565
Severe anxiety 28 18 27 19 26 19 81 19 Wald’s χ2=0.49, P=0.976
Depression symptoms (PHQ-9)
No depression 13 9 15 11 11 8 39 9 Wald’s χ2=0.76, P=0.683
Mild depression 56 37 50 36 53 38 159 37 Wald’s χ2=0.14, P=0.933
Moderate depression 47 31 48 34 51 36 146 34 Wald’s χ2=1.09, P=0.578
Moderately severe depression 29 19 24 17 17 12 70 16 Wald’s χ2=2.68, P=0.261
Severe depression 8 5 3 2 8 6 19 4 Wald’s χ2=2.55, P=0.279
GAD-7, 7-item Generalised Anxiety Disorder Scale; PHQ-9, 9-item Patient Health Questionnaire.
a. Categories of vocational status were not mutually exclusive; participants could indicate more than one to best describe their situation.




The Wellbeing Plus Course is an 8-week intervention that teaches
core transdiagnostic psychological principles and skills such as
cognitive challenging, exposure and behavioural activation that
have been found to be effective at reducing symptoms of
depression and anxiety in older adults.16,17,20 The Wellbeing Plus
Course consists of five online lessons, homework assignments and
case-enhanced stories, which detail the experiences of older adults
recovering from symptoms of depression and anxiety (Table 2).
Each lesson is presented in a slide show format that combines
didactic material (i.e. text-based instructions and information)
with case-enhanced stories. Participants are instructed to read the
lessons over 8 weeks according to a timetable. Participants also
receive regular automatic emails which notify them of new course
materials, reinforce completion of materials and practice of skills.
Participants are encouraged to complete one lesson every 7–10
days and to attempt to regularly practice the skills covered within
the lesson summaries.
Clinician contact
Participants in the iCG and iSG groups received a brief telephone
interview from one of the clinicians. This call was scripted and
aimed to: (a) discuss the aims of treatment; (b) convey hope by
describing the results of previous participants; (c) emphasise the
importance of consistent practice of the skills over time; and (d)
answer questions about the treatment. The interview calls were
designed to take between 10 and 20 min.
Participants in the iCG group also received weekly contact
from clinicians during treatment. Two registered and experienced
psychologists (V.F. and L.J.) provided all clinical contact with
participants, via telephone or a secure email system. In accordance
with previous research,29 clinicians were instructed to: (a) answer
participants’ questions; (b) summarise content; (c) encourage
skills practice; (d) resolve difficulties applying skills; and
(e) reinforce progress. Clinicians were instructed not to introduce
therapeutic skills not covered within the course and, unless
clinically indicated, to limit the time spent in contact or contacting
participants to approximately 10–15 min per week.
Participants in the iSG and SG groups were informed via the
online application system that they would not receive clinical
contact throughout treatment unless their symptoms became
more severe. The symptom questionnaire responses of partici-
pants in these groups were monitored weekly by the clinicians, but
contact was only initiated if a deterioration in their mental health
(i.e. defined as an increase in PHQ-9 total score of ≥5 with a total
score ≥15 or a PHQ-9 question 9 score of 3) was observed. This
contact involved the administration of a risk assessment and, if
needed, referral to appropriate crisis services.
Statistical analysis
All analyses were conducted using SPSS version 21. Group
differences in demographic variables and diagnostic variables
were analysed using binomial and multinomial logistic regression
and general linear models analyses. The alpha significance level for
the preliminary analyses was adjusted from 0.05 to 0.01 as a
partial control for the number of analyses conducted. Participants
who did not start the interventions were not included in any
analyses.
A generalised estimation equation (GEE) modelling technique
was employed to examine changes in the measures over time. An
unstructured working correlation structure was selected, coupled
with a robust error estimation, for GEE analyses. GEE models
specified a gamma distribution with a log-link response scale to
address skewness in the dependent variable distributions. Symp-
tom scores at the time of completing the online application were
employed as baseline for the primary measures. However, for the
secondary and tertiary outcomes, which were not assessed at
initial application, pre-treatment was used as baseline. SPSS
Table 2 Content of the Wellbeing Plus Course and recommended timetable
Lesson
Time before
next lesson Lesson content
Primary skill taught in lesson
and homework Additional resources
Lesson 1 1 week Education about the general prevalence and symptoms of anxiety
and low mood without mention of specific disorders. Introduction of
a cognitive–behavioural therapy model and explanation of the
functional relationship between physical, thought and behavioural
symptoms in psychological distress. Instructions for identifying their
own symptoms and how their symptoms interact. Transdiagnostic










Lesson 2 2 weeks Introduction to the basic principles of cognitive therapy and
importance of managing thoughts to manage anxiety and low mood.
Instructions for monitoring and challenging thoughts related to








Lesson 3 1 week Introduction to the physical symptoms of hyper-arousal and hypo-
arousal and their relationship to anxiety and low mood. Instructions
about managing physical symptoms using de-arousal strategies
such as controlled breathing and scheduling pleasant activities.





A list of 100 pleasant things to
do
Transdiagnostic case stories
Lesson 4 2 weeks Introduction to the behavioural symptoms of anxiety and low mood.
Explanation of avoidance and safety behaviours and their
relationship with ongoing distress. Instructions for graded exposure
for safely confronting fears and increasing activity levels.
Transdiagnostic vignettes and examples of graded exposure
provided.
Graded exposure Assertive communication
Transdiagnostic case stories
Lesson 5 2 weeks Information about the occurrence of lapses and the process of
recovery from anxiety and low mood. Information about the signs of
relapse and managing lapses. Instructions for creating a relapse
Relapse prevention Transdiagnostic case stories
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pairwise comparisons were used to examine significant main and
interaction effects. To determine whether the age of older adults
affected clinical outcomes, GEE analyses were repeated on the
primary outcomes using participant age as a model covariate.
In addition, three different statistics were calculated for
comparison and benchmarking purposes. First, the average
percentage change across time was calculated from the GEE
analyses for each of the outcome variables with 95% confidence
intervals. Second, Cohen’s d effect sizes and 95% confidence
intervals were calculated for the between-groups effects based on
the estimated marginal means derived from the GEE models. To
provide data about negative outcomes,30 the numbers of partici-
pants reporting symptom deteriorations ≥30% and symptoms in
the clinical ranges at post-treatment (i.e. above recognised clinical
cut-offs on the GAD-7 and PHQ-9) on the primary outcome
measures were also calculated.
Results
Baseline data, adherence and attrition
The demographic characteristics of the sample are shown in
Table 1. Participant flow, treatment attrition, lesson completion
and questionnaire response are shown in Fig. 1. As shown in Table
1, participants reported having had symptoms for several decades
and the majority had not sought professional help in the past 12
months. No differences were found between the groups on the
demographic variables. A minimum of 95% of participants in each
group completed questionnaires at post-treatment compared with
a minimum of 90% at 3-month follow-up. No differences were
found between participants who completed and did not complete
post-treatment questionnaires (Ps>0.01). The means, percentage
reductions and effect sizes for the groups are shown in Table 3.
Primary outcomes
The primary outcomes were depression and anxiety symptom
levels, which were assessed with the PHQ-9 and GAD-7
respectively. The GEE analyses indicated a significant effect for
time (PHQ-9: Wald’s χ2=738.80, P<0.001; GAD-7: Wald’s
χ2=682.88, P<0.001) but no significant time × group interactions
(PHQ-9: Wald’s χ2=4.34, P=0.362; GAD-7: Wald’s χ2=4.43,
P=0.351). Pairwise comparisons indicated that on the PHQ-9,
all groups reduced their symptoms from assessment to post-
treatment (P<0.001) but not from post-treatment to 3-month
follow-up (P=0.761). On the GAD-7, all groups reduced in their
symptoms from assessment to post-treatment (P<0.001) and from
post-treatment to 3-month follow-up (P=0.002).
Secondary outcomes
The secondary outcomes were geriatric-specific depression symp-
toms and general psychological distress, as measured by the GDS
and K-10 respectively. The GEE analyses indicated a significant
effect for time (GDS: Wald’s χ2=371.43, P<0.001; K-10: Wald’s
χ2=793.60, P<0.001) but no significant time × group interactions
(GDS: Wald’s χ2=6.52, P=0.164; K-10: Wald’s χ2=5.58, P=0.233).
Pairwise comparisons indicated that on both measures, all groups
showed significant symptom reduction from assessment to post-
treatment (P<0.001) and from post-treatment to 3-month follow-
up (P<0.001).
Tertiary outcomes
The tertiary outcomes were disability and satisfaction with life,
assessed with the SDS and SWLS respectively. Analyses indicated
a significant effect for time (SDS: Wald’s χ2=282.31, P<0.001;
SWLS: Wald’s χ2=241.25, P<0.001). All groups showed symptom
reduction from assessment to post-treatment (P<0.001) and from
post-treatment to 3-month follow-up in both disability and
satisfaction (P<0.009).
There was no significant time × group interaction for
disability (SDS: Wald’s χ2=1.71, P=0.790) but there was evidence
of an interaction for satisfaction with life (SWLS: Wald’s χ2=12.34,
P=0.015). Pairwise comparisons indicated that the iSG group
did not improve in satisfaction with life from post-treatment to
3-month follow-up (P=0.363), whereas the iCG and SG groups
did improve (Ps<0.003). However, there were no overall differ-
ences in satisfaction with life between the three groups at either
post-treatment (P range: 0.334–0.780) or at 3-month follow-up
(P range: 0.642–0.981).
Age and clinical outcomes
The GEE analyses revealed no significant effect for age (GAD-7:
Wald’s χ2=0.57, P=0.449; PHQ-9: Wald’s χ2=0.28, P=0.591) or
significant interactions on the primary outcomes (GAD-7: Wald’s
χ2=3.24, P=0.518; PHQ-9: Wald’s χ2=0.33, P=0.988) when age was
entered into the analyses as a covariate.
Clinician time
There were significant differences in clinician contact time
between groups (F=415.50, P<0.001). The iCG group received
more clinician time than the iSG and SG groups (Ps<0.001), but
there were no differences between the iSG and SG groups
(P=0.483). The mean total clinician time per participant in the
iCG group was 68.47 min (s.d.=34.35), which was comprised of
answering and making calls (total=1320; M=8.63 min; s.d.=2.80;
range 0–20) as well as reading, sending and responding to secure
emails (total=750; M=4.90; s.d.=2.78; range 0–12). Because of
technical difficulties and deterioration, 52% (73/140) of the iSG
group and 56% (79/140) of the SG group received one or more
contacts via email or telephone during treatment. The mean total
clinician time per participant in the iSG group was 4.61 min
(s.d.=8.08) and the mean total clinician time per participant in the
SG group was 6.43 min (s.d.=10.24).
Negative outcomes
Less than 1% (1/150), 3% (3/136) and 2% (2/133) in the iCG, iSG
and SG groups respectively had increases in depression scores
≥30% and also scored above clinical cut-off at post-treatment.
None of the iCG group, 3% (4/136) of the iSG and 2% (2/133) of
the SG groups respectively had increases in anxiety scores ≥30%
and scored above the clinical cut-off at post-treatment. No
participants reported symptom deteriorations or changes in
personal safety requiring referral to crisis services.
Treatment completion and satisfaction rates
There was no difference between groups in the number of lessons
completed at post-treatment (F=1.12, P=0.326) or follow-up
(F=2.18, P=0.114). Of the participants who completed the
evaluation questions at post-treatment, 95% (132/139), 94%
(117/124) and 91% (112/123) of participants in the iCG, iSG
and SG groups respectively, responded that they ‘would recom-
mend the course’ to others. Similarly, 94% (131/139), 92% (115/
124) and 95% (117/123) of participants in the iCG, iSG, and SG
groups respectively responded that the course was ‘worth their
time’. There were no differences between groups in the propor-
tions reporting they would recommend the course (F=0.92,



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Treating anxiety and depression in older adults
Discussion
The present study compared the efficacy and acceptability of three
support levels for a new transdiagnostic internet-delivered inter-
vention, the Wellbeing Plus Course, for adults aged 60 years and
above with symptoms of depression and anxiety. No differences
were found between the groups. High completion and accept-
ability rates were achieved in all three groups. All groups were
associated with significant reductions in symptoms and very low
rates (i.e. <4%) of symptom deterioration.
Similarly, large reductions in symptoms of depression
(Cohen’s d ≥1.30; average reduction ≥54%) and anxiety (Cohen’s
d ≥1.29; average reductions ≥50%) were observed across the three
treatment groups and were maintained or improved at follow-up.
The magnitude of the observed reductions are comparable with
other studies that have evaluated the efficacy of psychological
treatments for older adults when administered face to face31,32 and
via the internet.16–20 Significant improvements were also observed
on secondary and tertiary outcome measures, which included
satisfaction with life, improvements in psychological distress and
disability.
The present findings extend the literature in several ways.
First, the results from this large RCT augment existing studies
indicating that transdiagnostic treatments for symptoms of
anxiety or depression are not only effective for younger adults31,32
but also older adults.14,17 Second, the results of this study indicate
that clinician guidance or a pre-treatment telephone interview
with a clinician may not be necessary to achieve strong clinical
outcomes among older adults. This finding contributes to a
growing body of evidence indicating that carefully designed self-
guided treatments, which include automated prompts and other
features that improve engagement are able to produce high rates
of engagement and large clinical benefits.11–15 It is important to
note that the results of the present trial have been partially
replicated in an online national mental health service in Australia
which used the clinician-guided iCBT model described here.33
High rates of course completion, satisfaction and strong clinical
outcomes were observed in that sample of patients in routine
clinical care, indicating the intervention can be successfully
translated from a research setting into a routine clinical environ-
ment. This is consistent with recent results from other clinics
indicating that both younger and older adults can benefit from
iCBT when administered as part of routine clinical care.34–36 It is
also notable that participants in the present study reported having
had symptoms for several decades (M onset=33 years; s.d.=19)
and many (≥66%) had not sought professional help in the past 12
months, which highlight the public health potential of internet-
delivered psychological treatments to the large number of older
adults with untreated anxiety and depression.
This study has a number of limitations. First, the absence of a
control group means it is not possible to control for the effects of
spontaneous remission. However, controlled trials using similar
methods have found very little change in control groups (e.g.
Cohen’s ds<0.15) without active intervention,16,20 which may
reflect the chronicity of symptoms. Second, the present trial was
designed as a superiority trial and consequently caution is needed
in concluding any statistical findings as supporting clinical
equivalence, which requires the use of specific equivalence trial
analyses. Third, the results are based on self-reported symptom
scores. The absence of a formal diagnostic interview means that
some care is needed in generalising the results of the current study
to older adults meeting diagnostic criteria for anxiety and
depressive disorders. Fourth, it is unclear whether the current
results would be maintained beyond the 3-month follow-up






































































































































































































































































































































































































































































































































































































































































































































































































































evident at 12-month follow-up.16,20 A further limitation of the
current study is that it used a sample of older adults who were
both seeking psychological treatment and were comfortable
enough with the use of computers to participate in the study.
Some caution is therefore needed in generalising the results to
older adults presenting to other settings and who may not be
interested in psychological treatment or are not sufficiently
confident with computers.
Two further considerations are the nature of the intervention
and the nature of support that was available to patients if needed.
The Wellbeing Plus Course has been carefully developed over
several phases of research, with each version evaluated in clinical
trials and modified with the help of feedback from large numbers
of participants. Moreover, the self-reported symptoms of all
participants were carefully monitored during treatment and half
of those in the self-guided groups were contacted, even if only
briefly, by a clinician to check their safety or assist with technical
difficulties during treatment. Hence, this model of self-guided
treatment differs from fully automated interventions in facilitating
the safety and engagement of participants, whereas still represent-
ing a cost-effective method of administration.
In conclusion, these results extend evidence indicating that
CBT can help older adults recover from symptoms of anxiety and
depression. The results also indicate that carefully developed
clinician-guided and self-guided iCBT interventions, delivered
either with and without a clinical interview, can result in similarly
high treatment completion rates, levels of satisfaction and large
clinical outcomes. The findings of the current trial further
highlight the considerable potential of iCBT and interventions
like the Wellbeing Plus Course to improve access to treatment for
older adults with anxiety and depression who might otherwise
never receive treatment.
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